Skip to content

Bringing together opposites: how dialogue groups are helping to reduce HIV risk behaviour in Africa and Miami

Cancer: further evidence that long-term immune suppression will boost risk for people with HIV

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

Indian HIV estimate cut to 2.5 million people

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

Thai programme demonstrates HIV services can be successfully delivered in prison

Brazil: Kaletra price cut agreed as generic efavirenz arrives

Infant ARV treatment study shows advantage for immediate treatment

Risk of viral rebound decreases with longer treatment, even with previous failures